AKANDA CORP.

AKANDA CORP.

Share · CA00971M2058 · AKAN · A3D77A (XNCM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of AKANDA CORP.
No Price
28.04.2026 23:59
Current Prices from AKANDA CORP.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AKAN
USD
28.04.2026 23:59
15,80 USD
3,70 USD
+30,58 %
IEXG: IEX
IEX
AKAN
USD
28.04.2026 20:57
18,54 USD
6,44 USD
+53,22 %
Company Profile for AKANDA CORP. Share
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Company Data

Name AKANDA CORP.
Company Akanda Corp.
Symbol AKAN
Website https://www.akandacorp.com
Primary Exchange XNCM Frankfurt
WKN A3D77A
ISIN CA00971M2058
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Katharyn Field
Country United Kingdom
Currency EUR
Employees 0,0 T
Address 1a, 1b Learoyd Road, TN28 8XU New Romney
IPO Date 2022-03-15

Stock Splits

Date Split
13.04.2026 1:4.5
12.01.2026 1:5
26.08.2025 1:3.125
14.11.2024 1:2
23.05.2024 1:40
09.03.2023 1:10

Ticker Symbols

Name Symbol
NASDAQ AKAN
More Shares
Investors who hold AKANDA CORP. also have the following shares in their portfolio:
BRIACELL THERAPEUTICSCS CORP - WARRANT
BRIACELL THERAPEUTICSCS CORP - WARRANT Share
Consolidated Construction Consortium Limited
Consolidated Construction Consortium Limited Share